SCHEMBL903045

SCHEMBL903045

O=[N+]([O-])c1cnc(N2CCNCC2)c(Br)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
ADRB1 P08588 1/20 0.48
SIRT6 Q8N6T7 1/20 0.48
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
SLC6A4 P31645 1/20 0.44
CYP2C19 P33261 1/20 0.44
THPO P40225 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
HTR1A P08908 1/20 0.42
HTR7 P34969 1/20 0.42
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL907889 0.84 ALDH1A1 (0.54) ALDH1A1MAPK1HTTADRB1SIRT6
SCHEMBL9684591 0.84 ALDH1A1 (0.74) ALDH1A1MAPK1HTTADRB1SIRT6
SCHEMBL29046091 0.83 ALDH1A1 (0.56) ALDH1A1MAPK1HTTADRB1SIRT6
SCHEMBL899829 0.83 ALDH1A1 (0.52) ALDH1A1MAPK1HTTADRB1SIRT6
SCHEMBL30412573 0.83 ALDH1A1 (0.56) ALDH1A1MAPK1HTTADRB1SIRT6
SCHEMBL25001976 0.83 ALDH1A1 (0.52) ALDH1A1MAPK1HTTSIRT6CYP1A2
SCHEMBL3363772 0.83 ALDH1A1 (0.56) ALDH1A1MAPK1HTTCYP1A2CYP2C19
Hydrochloric Acid SCHEMBL3174215 0.83 ALDH1A1 (0.52) ALDH1A1MAPK1HTTADRB1SIRT6
Hydrochloric Acid SCHEMBL23612041 0.82 ALDH1A1 (0.51) ALDH1A1MAPK1HTTADRB1SIRT6
SCHEMBL31378764 0.80 ALDH1A1 (0.49) ALDH1A1MAPK1HTTADRB1SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621920-B1 NOVEL PIPERAZINE ANALOGS WITH SUBSTITUTED HETEROARYL GROUPS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL MYERS SQUIBB CO (US) 2016-01-27 EP disclosed
EP-2621920-B1 NOVEL PIPERAZINE ANALOGS WITH SUBSTITUTED HETEROARYL GROUPS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL MYERS SQUIBB CO (US) 2016-01-27 EP disclosed
US-20120245176-A1 NOVEL PIPERAZINE ANALOGS WITH SUBSTITUTED HETEROARYL GROUPS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL-MYERS SQUIBB COMPANY 2012-09-27 US disclosed
US-20120245176-A1 NOVEL PIPERAZINE ANALOGS WITH SUBSTITUTED HETEROARYL GROUPS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL-MYERS SQUIBB COMPANY 2012-09-27 US disclosed
WO-2012044531-A1 NOVEL PIPERAZINE ANALOGS WITH SUBSTITUTED HETEROARYL GROUPS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120245176-A1 NOVEL PIPERAZINE ANALOGS WITH SUBSTITUTED HETEROARYL GROUPS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS ZC3HAV1, ZC3HAV1L, BAZ2A ALDH1A1 2107/4885MAPK1 3190/4885HTT 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.